Abstract:Objective The aim of the present study was not only to assess the retrograde degenerative changes in the dopaminergic neurons of the substantia nigra (SN) and ventral tegmental area (VTA) after injection of 6-hydroxydopamine (6-OHDA) into the striatum, but also to use this 6-OHDA model of Parkinson's disease to explore the possible neuroprotective effect of R-apomorphine (R-APO). Methods The partial lesion was obtained by intrastriatal administration of 6-OHDA. R-APO administration (10 mg/kg, s.c.) started 15 min prior to lesioning and continued daily for another 22 days post surgery. Testing was carried out 5 weeks after lesioning. We investigated the histology and associated behavior and neurochemical changes. Structural and functional deficits were quantified by tyrosine hydroxylase (TH) / Nissl-staining cell number counting, striatal dopamine (DA) content determination and amphetamine-induced rotation analysis. Results R-APO-treatment attenuated the amphetamine-induced ipsiversive rotation 5 weeks after the lesion induction. R-APO administration for 22 days significantly reduced the size of the lesion at the level of the SN from 50% (control group) to 69%. Moreover, the cell shape resembled that observed in the intact animals. R-APO treatment significantly increased the number of cells in both the lesion and the intact sides of VTA by 60%, suggesting selective neurotrophic effect of R-APO in this area. Finally, R-APO-treatment significantly attenuated the 6-OHDA-induced striatal DA depletion and normalized dihydroxyphenylacetic acid (DOPAC)/DA ratios. Conclusion We conclude that R-APO has neuroprotective and possible neurotrophic effect on a striatal lesion with 6-OHDA, suggesting that this drug may have rescuing properties in patients with early stage Parkinson's disease. These effects are more pronounced in VTA and enhance with duration of treatment.

Dopamine depletion abolishes apomorphine- and amphetamine-induced increases in extracellular serotonin levels in the striatum of conscious rats: a microdialysis study

Effects of Chronic, Systemic Treatment with the Dopamine Receptor Agonist R-apomorphine in Partially Lesioned Rat Model of Parkinson's Disease: an Electrophysiological Study of Substantia Nigra Dopamine Neurons.

Unilateral Lesion of the Nigrostriatal Pathway Induces an Increase of Neuronal Firing of the Midbrain Raphe Nuclei 5-HT Neurons and a Decrease of Their Response to 5-HT(1A) Receptor Stimulation in the Rat.

Alterations in 5-HT<sub>2A</sub>receptor binding in various brain regions among 6-hydroxydopamine-induced Parkinsonian rats

Serotonergic sprouting is induced by dopamine-lesion in substantia nigra of adult rat brain

Alterations in 5-HT2A receptor binding in various brain regions among 6-hydroxydopamine-induced Parkinsonian rats.

Serotonin6 receptors in the dorsal hippocampus regulate depressive-like behaviors in unilateral 6-hydroxydopamine-lesioned Parkinson's rats.

Changes in the Firing Activity of Serotonergic Neurons in the Dorsal Raphe Nucleus in a Rat Model of Parkinson's Disease.

R-apomorphine Protects Against 6-Hydroxydopamine-induced Nigrostriatal Damage in Rat.

Comparative Effects of Infusions of 6-Hydroxydopamine into Nucleus Accumbens and Anterolateral Hypothalamus Induced by 6-Hydroxydopamine on the Response to Dopamine Agonists, Body Weight, Locomotor Activity and Measures of Exploration in the Rat

Activation and Blockade of Serotonin(6) Receptors in the Dorsal Hippocampus Enhance T Maze and Hole-Board Performance in A Unilateral 6-Hydroxydopamine Rat Model of Parkinson'S Disease

Serotonergic and dopaminergic neurons in the dorsal raphe are differentially altered in a mouse model for parkinsonism

High-frequency stimulation of the subthalamic nucleus and L-3,4-dihydroxyphenylalanine inhibit in vivo serotonin release in the prefrontal cortex and hippocampus in a rat model of Parkinson's disease

Lesions Of Mouse Striatum Induced By 6-Hydroxydopamine Differentially Alter The Density, Rate Of Synthesis, And Level Of Gene-Expression Of D-1 And D-2 Dopamine-Receptors

Alterations in Serotonin Neurotransmission in Hyperdopaminergic Rats Lacking the Dopamine Transporter

5-HT4R agonism reduces L-DOPA-induced dyskinesia via striatopallidal neurons in unilaterally 6-OHDA lesioned mice

Decreased Response of Interneurons in the Medial Prefrontal Cortex to 5-Ht1a Receptor Activation in the Rat 6-Hydroxydopamine Parkinson Model

Alterations of Emotion, Cognition and Firing Activity of the Basolateral Nucleus of the Amygdala after Partial Bilateral Lesions of the Nigrostriatal Pathway in Rats

Effects of D-Amphetamine and Apomorphine Upon Operant Behavior and Schedule-Induced Licking in Rats with 6-Hydroxydopamine-induced Lesions of the Nucleus Accumbens.

Effects of 6-Hydroxydopamine Lesions of the Nucleus Accumbens Septi and Olfactory Tubercle on Feeding, Locomotor Activity, and Amphetamine Anorexia in the Rat.

Increase in Glutamatergic Terminals in the Striatum Following Dopamine Depletion in a Rat Model of Parkinson’s Disease